Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2

DOI record: { "DOI": "10.1038/s41598-025-05683-w", "ISSN": [ "2045-2322" ], "URL": "http://dx.doi.org/10.1038/s41598-025-05683-w", "alternative-id": [ "5683" ], "article-number": "21627", "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "20 November 2024" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "3 June 2025" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "1 July 2025" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors declare no competing interests." } ], "author": [ { "affiliation": [], "family": "Ferreira", "given": "Iasmin Rosanne Silva", "sequence": "first" }, { "affiliation": [], "family": "Justino", "given": "Isabela Araújo", "sequence": "additional" }, { "affiliation": [], "family": "Martins", "given": "Ronaldo Bragança", "sequence": "additional" }, { "affiliation": [], "family": "Souza", "given": "Maria Vitória Oliveira", "sequence": "additional" }, { "affiliation": [], "family": "de Lima", "given": "Thais Melquiades", "sequence": "additional" }, { "affiliation": [], "family": "de Freitas Pinheiro", "given": "Ana Maria", "sequence": "additional" }, { "affiliation": [], "family": "Arruda", "given": "Eurico", "sequence": "additional" }, { "affiliation": [], "family": "Bastos", "given": "Jairo Kenupp", "sequence": "additional" }, { "affiliation": [], "family": "Marcato", "given": "Priscyla Daniely", "sequence": "additional" } ], "container-title": "Scientific Reports", "container-title-short": "Sci Rep", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T18:22:42Z", "timestamp": 1751394162000 }, "deposited": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T19:09:31Z", "timestamp": 1751396971000 }, "funder": [ { "DOI": "10.13039/501100001807", "award": [ "#2017/04138-8", "#2017/04138-8" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100001807", "id-type": "DOI" } ], "name": "Fundação de Amparo à Pesquisa do Estado de São Paulo" }, { "DOI": "10.13039/501100003593", "award": [ "# 465687/2014-8" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100003593", "id-type": "DOI" } ], "name": "Conselho Nacional de Desenvolvimento Científico e Tecnológico" } ], "indexed": { "date-parts": [ [ 2025, 7, 2 ] ], "date-time": "2025-07-02T04:20:36Z", "timestamp": 1751430036829, "version": "3.41.0" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2025, 7, 1 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2025, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T00:00:00Z", "timestamp": 1751328000000 } }, { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T00:00:00Z", "timestamp": 1751328000000 } } ], "link": [ { "URL": "https://www.nature.com/articles/s41598-025-05683-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s41598-025-05683-w", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s41598-025-05683-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1038", "published": { "date-parts": [ [ 2025, 7, 1 ] ] }, "published-online": { "date-parts": [ [ 2025, 7, 1 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.3390/ijms21072657", "doi-asserted-by": "publisher", "key": "5683_CR1", "unstructured": "Tu, Y. F. et al. A review of sars-cov-2 and the ongoing clinical trials. International Journal of Molecular Sciences vol. 21 Preprint at (2020). https://doi.org/10.3390/ijms21072657" }, { "DOI": "10.1007/978-1-61779-953-2_41", "author": "M Wright", "doi-asserted-by": "publisher", "first-page": "511", "journal-title": "Methods Mol. Biol.", "key": "5683_CR2", "unstructured": "Wright, M. Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. Methods Mol. Biol. 906, 511–524 (2012).", "volume": "906", "year": "2012" }, { "key": "5683_CR3", "unstructured": "WHO Coronavirus (COVID-19) Dashboard. (2023). https://covid19.who.int" }, { "DOI": "10.3389/fpubh.2020.00365", "doi-asserted-by": "publisher", "key": "5683_CR4", "unstructured": "Huang, L. et al. Progress in the Research and Development of Anti-COVID-19 Drugs. Frontiers in Public Health vol. 8 Preprint at (2020). https://doi.org/10.3389/fpubh.2020.00365" }, { "DOI": "10.1183/16000617.0185-2021", "doi-asserted-by": "publisher", "key": "5683_CR5", "unstructured": "Montani, D. et al. Post-acute COVID-19 syndrome. European Respiratory Review vol. 31 Preprint at (2022). https://doi.org/10.1183/16000617.0185-2021" }, { "DOI": "10.33448/rsd-v12i4.41092", "author": "NB Maniçoba", "doi-asserted-by": "publisher", "first-page": "e17812441092", "journal-title": "Res. Soc. Dev.", "key": "5683_CR6", "unstructured": "Maniçoba, N. B. et al. Post-acute COVID-19 syndrome and musculoskeletal manifestations: an overview. Res. Soc. Dev. 12, e17812441092 (2023).", "volume": "12", "year": "2023" }, { "DOI": "10.1038/s41586-020-2665-2", "author": "Z Ke", "doi-asserted-by": "publisher", "first-page": "498", "journal-title": "Nature", "key": "5683_CR7", "unstructured": "Ke, Z. et al. Structures and distributions of SARS-CoV-2 Spike proteins on intact virions. Nature 588, 498–502 (2020).", "volume": "588", "year": "2020" }, { "DOI": "10.1016/j.virusres.2020.198141", "author": "SK Samrat", "doi-asserted-by": "publisher", "first-page": "Preprintathttps", "journal-title": "Virus Res.", "key": "5683_CR8", "unstructured": "Samrat, S. K., Tharappel, A. M., Li, Z. & Li, H. Prospect of SARS-CoV-2 Spike protein: potential role in vaccine and therapeutic development. Virus Res. 288, Preprintathttpsdoiorg101016jvirusres2020198141 (2020).", "volume": "288", "year": "2020" }, { "DOI": "10.3390/ijms24010020", "doi-asserted-by": "crossref", "key": "5683_CR9", "unstructured": "Yamamoto, Y. et al. Direct Inhibition of SARS-CoV-2 Spike protein by peracetic acid. Int J. Mol. Sci 24, 1–15 (2023)." }, { "DOI": "10.1155/2016/6057650", "doi-asserted-by": "crossref", "key": "5683_CR10", "unstructured": "Machado, C. S. et al. Comparative Study of Chemical Composition and Biological Activity of Yellow, Green, Brown, and Red Brazilian Propolis. Evidence-based Complementary and Alternative Medicine (2016). (2016)." }, { "DOI": "10.1002/ptr.6875", "author": "FP Beserra", "doi-asserted-by": "publisher", "first-page": "2274", "journal-title": "Phytother. Res.", "key": "5683_CR11", "unstructured": "Beserra, F. P. et al. Artepillin C as an outstanding phenolic compound of Brazilian green propolis for disease treatment: A review on Pharmacological aspects. Phytother. Res. 35, 2274–2286 (2021).", "volume": "35", "year": "2021" }, { "DOI": "10.1016/j.jep.2018.08.006", "author": "P Costa", "doi-asserted-by": "publisher", "first-page": "82", "journal-title": "J. Ethnopharmacol.", "key": "5683_CR12", "unstructured": "Costa, P. et al. Artepillin C, drupanin, aromadendrin-4′-O-methyl-ether and Kaempferide from Brazilian green propolis promote gastroprotective action by diversified mode of action. J. Ethnopharmacol. 226, 82–89 (2018).", "volume": "226", "year": "2018" }, { "author": "H Sobhani", "first-page": "3", "journal-title": "Iran. J. Pharm. Res.", "key": "5683_CR13", "unstructured": "Sobhani, H. et al. Formulation development and toxicity assessment of Triacetin mediated nanoemulsions as novel delivery systems for Rapamycin. Iran. J. Pharm. Res. 14, 3–21 (2015).", "volume": "14", "year": "2015" }, { "DOI": "10.3390/molecules25204612", "doi-asserted-by": "crossref", "key": "5683_CR14", "unstructured": "Xu, X. et al. The chemical composition of Brazilian green propolis and its protective effects on mouse aortic endothelial cells against inflammatory injury. Molecules 25, 1–12 (2020)." }, { "DOI": "10.1590/1678-992x-2018-0258", "doi-asserted-by": "crossref", "key": "5683_CR15", "unstructured": "Tomazzoli, M. M. et al. Botanical source investigation and evaluation of the effect of seasonality on Brazilian propolis from apis mellifera L. Sci Agric 77, 1–8 (2020)." }, { "DOI": "10.3390/foods10081776", "author": "N Yosri", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Foods", "key": "5683_CR16", "unstructured": "Yosri, N. et al. Anti-Viral and Immunomodulatory properties of propolis: chemical diversity, Pharmacological properties, preclinical and clinical applications, and in Silico potential against SARS-CoV-2. Foods 10, 1–47 (2021).", "volume": "10", "year": "2021" }, { "DOI": "10.1080/09603123.2022.2110576", "author": "NP Silva-Beltrán", "doi-asserted-by": "publisher", "first-page": "1591", "journal-title": "Int. J. Environ. Health Res.", "key": "5683_CR17", "unstructured": "Silva-Beltrán, N. P. et al. In vitro antiviral effect of Mexican and Brazilian propolis and phenolic compounds against human coronavirus 229E. Int. J. Environ. Health Res. 33, 1591–1603 (2022).", "volume": "33", "year": "2022" }, { "DOI": "10.1093/JPP/RGAA067", "doi-asserted-by": "publisher", "key": "5683_CR18", "unstructured": "Ripari, N. et al. Propolis antiviral and immunomodulatory activity: A review and perspectives for COVID-19 treatment. Journal of Pharmacy and Pharmacology vol. 73 281–299 Preprint at (2021). https://doi.org/10.1093/JPP/RGAA067" }, { "DOI": "10.6061/clinics/2021/e2357", "author": "AC Fiorini", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Clinics", "key": "5683_CR19", "unstructured": "Fiorini, A. C. et al. Antiviral activity of Brazilian green propolis extract against sars-cov-2 (Severe acute respiratory syndrome-coronavirus 2) infection: case report and review. Clinics 76, 1–4 (2021).", "volume": "76", "year": "2021" }, { "DOI": "10.1093/jpp/rgad030", "author": "IA Justino", "doi-asserted-by": "publisher", "first-page": "806", "journal-title": "J. Pharm. Pharmacol.", "key": "5683_CR20", "unstructured": "Justino, I. A. et al. Brazilian red propolis extract free and encapsulated into polymeric nanoparticles against ovarian cancer: formulation, characterisation and biological assays in 2D and 3D models. J. Pharm. Pharmacol. 75, 806–818 (2023).", "volume": "75", "year": "2023" }, { "DOI": "10.1186/s12986-021-00639-z", "author": "P Anvarifard", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Nutr. Metab. (Lond)", "key": "5683_CR21", "unstructured": "Anvarifard, P., Anbari, M., Ostadrahimi, A., Ardalan, M. & Ghoreishi, Z. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Nutr. Metab. (Lond). 19, 1–23 (2022).", "volume": "19", "year": "2022" }, { "DOI": "10.1186/s12951-018-0392-8", "doi-asserted-by": "publisher", "key": "5683_CR22", "unstructured": "Patra, J. K. et al. Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology vol. 16 Preprint at (2018). https://doi.org/10.1186/s12951-018-0392-8" }, { "DOI": "10.1021/acsnano.0c02540", "doi-asserted-by": "publisher", "key": "5683_CR23", "unstructured": "Chan, W. C. W. Nano Research for COVID-19. ACS Nano vol. 14 3719–3720 Preprint at (2020). https://doi.org/10.1021/acsnano.0c02540" }, { "DOI": "10.1016/j.cis.2020.102227", "author": "M Jalali-Jivan", "doi-asserted-by": "publisher", "first-page": "102227", "journal-title": "Adv. Colloid Interface Sci.", "key": "5683_CR24", "unstructured": "Jalali-Jivan, M., Garavand, F. & Jafari, S. M. Microemulsions as nano-reactors for the solubilization, separation, purification and encapsulation of bioactive compounds. Adv. Colloid Interface Sci. 283, 102227 (2020).", "volume": "283", "year": "2020" }, { "DOI": "10.1016/j.foodchem.2021.130376", "author": "F Garavand", "doi-asserted-by": "publisher", "first-page": "130376", "journal-title": "Food Chem.", "key": "5683_CR25", "unstructured": "Garavand, F., Jalai-Jivan, M., Assadpour, E. & Jafari, S. M. Encapsulation of phenolic compounds within nano/microemulsion systems: A review. Food Chem. 364, 130376 (2021).", "volume": "364", "year": "2021" }, { "DOI": "10.1080/03639045.2016.1235186", "author": "FH Xavier-Junior", "doi-asserted-by": "publisher", "first-page": "700", "journal-title": "Drug Dev. Ind. Pharm.", "key": "5683_CR26", "unstructured": "Xavier-Junior, F. H., Vauthier, C., Morais, A. R. V., Alencar, E. N. & Egito, E. S. T. Microemulsion systems containing bioactive natural oils: an overview on the state of the Art. Drug Dev. Ind. Pharm. 43, 700–714 (2017).", "volume": "43", "year": "2017" }, { "DOI": "10.1016/j.ijbiomac.2014.01.041", "author": "Y Fan", "doi-asserted-by": "publisher", "first-page": "200", "journal-title": "Int. J. Biol. Macromol.", "key": "5683_CR27", "unstructured": "Fan, Y. et al. The design of propolis flavone microemulsion and its effect on enhancing the immunity and antioxidant activity in mice. Int. J. Biol. Macromol. 65, 200–207 (2014).", "volume": "65", "year": "2014" }, { "DOI": "10.1155/2016/8175265", "doi-asserted-by": "crossref", "key": "5683_CR28", "unstructured": "Žilius, M., Ramanauskiene, K., Juškaite, V. & Briedis, V. Formulation of Propolis Phenolic Acids Containing Microemulsions and Their Biopharmaceutical Characterization. Evidence-based Complementary and Alternative Medicine (2016). (2016)." }, { "DOI": "10.1080/03639040600599806", "author": "L Montenegro", "doi-asserted-by": "publisher", "first-page": "539", "journal-title": "Drug Dev. Ind. Pharm.", "key": "5683_CR29", "unstructured": "Montenegro, L., Carbone, C., Condorelli, G., Drago, R. & Puglisi, G. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. Drug Dev. Ind. Pharm. 32, 539–548 (2006).", "volume": "32", "year": "2006" }, { "DOI": "10.4314/tjpr.v12i2.19", "doi-asserted-by": "crossref", "key": "5683_CR30", "unstructured": "Honary, S. & Zahir, F. Effect of zeta potential on the properties of Nano-Drug delivery Systems - A review (Part 2). Tropical J. Pharm. Research 12, 265–273 (2013)." }, { "DOI": "10.3390/iocn2023-14528", "doi-asserted-by": "publisher", "key": "5683_CR31", "unstructured": "Monakhova, P. A., Shalaev, P. V. & Gorev, I. N. Rapid characterization of synthesized nanoparticles’ liquid dispersions using nanoparticle tracking analysis. in 65 (2023). https://doi.org/10.3390/iocn2023-14528" }, { "DOI": "10.1155/2017/1231464", "author": "LNM Ribeiro", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Int. J. Polym. Sci.", "key": "5683_CR32", "unstructured": "Ribeiro, L. N. M. et al. Advances in hybrid Polymer-Based materials for sustained drug release. Int. J. Polym. Sci. 2017, 1–16 (2017).", "volume": "2017", "year": "2017" }, { "DOI": "10.1007/s12247-022-09668-4", "author": "L Lamoudi", "doi-asserted-by": "publisher", "first-page": "621", "journal-title": "J. Pharm. Innov.", "key": "5683_CR33", "unstructured": "Lamoudi, L., Akretche, S., Hadjsadok, A. & Daoud, K. Fusidic acid microemulsion based on a pseudoternary phase diagram: development, characterization, and evaluation. J. Pharm. Innov. 18, 621–628 (2023).", "volume": "18", "year": "2023" }, { "author": "A Hazem", "first-page": "868", "journal-title": "Farmacia", "key": "5683_CR34", "unstructured": "Hazem, A. et al. The antiviral/virucidal effects of alchoolic and aqueous extracts with propolis. Farmacia 65, 868–876 (2017).", "volume": "65", "year": "2017" }, { "DOI": "10.1016/j.biopha.2020.110622", "author": "AA Berretta", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Biomed. Pharmacother.", "key": "5683_CR35", "unstructured": "Berretta, A. A., Silveira, M. A. D., Cóndor Capcha, J. M. & De Jong, D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomed. Pharmacother. 131, 1–16 (2020).", "volume": "131", "year": "2020" }, { "DOI": "10.1007/s11356-022-21652-6", "author": "S Ghosh", "doi-asserted-by": "publisher", "first-page": "58628", "journal-title": "Environ. Sci. Pollut. Res.", "key": "5683_CR36", "unstructured": "Ghosh, S. et al. Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulations. Environ. Sci. Pollut. Res. 29, 58628–58647 (2022).", "volume": "29", "year": "2022" }, { "DOI": "10.1016/j.jksus.2020.101297", "doi-asserted-by": "crossref", "key": "5683_CR37", "unstructured": "Khayrani, A. C. et al. Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular Docking for COVID-19 drug discovery preliminary study. J King Saud Univ. Sci 33, 1–2 (2021)." }, { "DOI": "10.1080/07853890.2022.2031274", "author": "Q Fernandes", "doi-asserted-by": "publisher", "first-page": "524", "journal-title": "Ann. Med.", "key": "5683_CR38", "unstructured": "Fernandes, Q. et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 54, 524–540 (2022).", "volume": "54", "year": "2022" }, { "DOI": "10.1016/j.bjid.2021.101588", "author": "JC da Silva", "doi-asserted-by": "publisher", "first-page": "101588", "journal-title": "Brazilian J. Infect. Dis.", "key": "5683_CR39", "unstructured": "da Silva, J. C., Félix, V. B., Leão, S. A. B. F., Trindade-Filho, E. M. & Scorza, F. A. New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state. Brazilian J. Infect. Dis. 25, 101588 (2021).", "volume": "25", "year": "2021" }, { "author": "S Alexandar", "first-page": "83", "journal-title": "Int. J. Pharmacol. Clin. Res.", "key": "5683_CR40", "unstructured": "Alexandar, S., Ravisankar, M., Kumar, R. S. & Jakkan, K. A comprehensive review on Covid-19 Delta variant. Int. J. Pharmacol. Clin. Res. 5, 83–85 (2021).", "volume": "5", "year": "2021" }, { "DOI": "10.1002/jmv.27588", "author": "Y Araf", "doi-asserted-by": "publisher", "first-page": "1825", "journal-title": "J. Med. Virol.", "key": "5683_CR41", "unstructured": "Araf, Y. et al. Omicron variant of SARS-CoV‐2: genomics, transmissibility, and responses to current COVID‐19 vaccines. J. Med. Virol. 94, 1825–1832 (2022).", "volume": "94", "year": "2022" }, { "DOI": "10.1016/j.cell.2020.02.052", "author": "M Hoffmann", "doi-asserted-by": "publisher", "first-page": "271", "journal-title": "Cell", "key": "5683_CR42", "unstructured": "Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280e8 (2020).", "volume": "181", "year": "2020" }, { "DOI": "10.1016/j.ijpharm.2020.120028", "author": "H Refaat", "doi-asserted-by": "publisher", "first-page": "120028", "journal-title": "Int. J. Pharm.", "key": "5683_CR43", "unstructured": "Refaat, H., Mady, F. M., Sarhan, H. A., Rateb, H. S. & Alaaeldin, E. Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. Int. J. Pharm. 592, 120028 (2021).", "volume": "592", "year": "2021" }, { "DOI": "10.12659/MSM.897282", "author": "A Yildirim", "doi-asserted-by": "publisher", "first-page": "422", "journal-title": "Med. Sci. Monit.", "key": "5683_CR44", "unstructured": "Yildirim, A. et al. Antiviral activity of Hatay propolis against replication of herpes simplex virus type 1 and type 2. Med. Sci. Monit. 22, 422–430 (2016).", "volume": "22", "year": "2016" }, { "author": "K Labská", "first-page": "733", "journal-title": "Pharmazie", "key": "5683_CR45", "unstructured": "Labská, K., Plodková, H., Pumannová, M. & Sensch, K. H. Antiviral activity of propolis special extract GH 2002 against varicella Zoster virus in vitro. Pharmazie 73, 733–736 (2018).", "volume": "73", "year": "2018" }, { "DOI": "10.1007/s11356-019-07458-z", "author": "NP Silva-Beltrán", "doi-asserted-by": "publisher", "first-page": "28510", "journal-title": "Environ. Sci. Pollut. Res.", "key": "5683_CR46", "unstructured": "Silva-Beltrán, N. P., Balderrama-Carmona, A. P. & Umsza-Guez, M. A. Souza machado, B. A. Antiviral effects of Brazilian green and red propolis extracts on enterovirus surrogates. Environ. Sci. Pollut. Res. 27, 28510–28517 (2020).", "volume": "27", "year": "2020" }, { "DOI": "10.3390/biomedicines7040073", "author": "P Governa", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Biomedicines", "key": "5683_CR47", "unstructured": "Governa, P. et al. Beyond the biological effect of a chemically characterized Poplar propolis: antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells. Biomedicines 7, 1–10 (2019).", "volume": "7", "year": "2019" }, { "DOI": "10.1016/j.jep.2005.05.045", "author": "G Gekker", "doi-asserted-by": "publisher", "first-page": "158", "journal-title": "J. Ethnopharmacol.", "key": "5683_CR48", "unstructured": "Gekker, G., Hu, S., Spivak, M., Lokensgard, J. R. & Peterson, P. K. Anti-HIV-1 activity of propolis in CD4 + lymphocyte and microglial cell cultures. J. Ethnopharmacol. 102, 158–163 (2005).", "volume": "102", "year": "2005" }, { "DOI": "10.4314/ajtcam.v12i4.16", "author": "M de Búrquez", "doi-asserted-by": "publisher", "first-page": "106", "journal-title": "Afr. J. Tradit. Complement. Altern. Med.", "key": "5683_CR49", "unstructured": "de Búrquez, M. Protective effect of a Mexican propolis on MDBK cells exposed to aujeszky’s disease virus (pseudorabies virus). Afr. J. Tradit. Complement. Altern. Med. 12, 106–111 (2015).", "volume": "12", "year": "2015" }, { "DOI": "10.1002/ptr.5054", "author": "H Maruta", "doi-asserted-by": "publisher", "first-page": "656", "journal-title": "Phytother. Res.", "key": "5683_CR50", "unstructured": "Maruta, H. Herbal therapeutics that block the oncogenic kinase PAK1: A practical approach towards PAK1-dependent diseases and longevity. Phytother. Res. 28, 656–672 (2014).", "volume": "28", "year": "2014" }, { "DOI": "10.3109/08923973.2012.657304", "author": "Y Okamoto", "doi-asserted-by": "publisher", "first-page": "803", "journal-title": "Immunopharmacol. Immunotoxicol", "key": "5683_CR51", "unstructured": "Okamoto, Y., Tanaka, M., Fukui, T. & Masuzawa, T. Brazilian propolis inhibits the differentiation of Th17 cells by Inhibition of interleukin-6-induced phosphorylation of signal transducer and activator of transcription 3. Immunopharmacol. Immunotoxicol. 34, 803–809 (2012).", "volume": "34", "year": "2012" }, { "DOI": "10.1155/2013/418508", "author": "JI Hori", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Evidence-Based Complement. Altern. Med.", "key": "5683_CR52", "unstructured": "Hori, J. I., Zamboni, D. S., Carrão, D. B., Goldman, G. H. & Berretta, A. A. The Inhibition of inflammasome by Brazilian Propolis (EPP-AF). Evidence-Based Complement. Altern. Med. 2013, 1–11 (2013).", "volume": "2013", "year": "2013" }, { "DOI": "10.2174/1872214808666140619115319", "author": "S Figueiredo", "doi-asserted-by": "publisher", "first-page": "85", "journal-title": "Recent. Pat. Endocr. Metab. Immune Drug Discov", "key": "5683_CR53", "unstructured": "Figueiredo, S. et al. Immunomodulatory properties of green Propolis. Recent. Pat. Endocr. Metab. Immune Drug Discov. 8, 85–94 (2014).", "volume": "8", "year": "2014" }, { "DOI": "10.1016/j.medidd.2020.100039", "author": "H Maruta", "doi-asserted-by": "publisher", "first-page": "100039", "journal-title": "Med. Drug Discov", "key": "5683_CR54", "unstructured": "Maruta, H. & He, H. PAK1-blockers: potential therapeutics against COVID-19. Med. Drug Discov. 6, 100039 (2020).", "volume": "6", "year": "2020" }, { "DOI": "10.1016/j.jep.2006.10.023", "author": "I Jasprica", "doi-asserted-by": "publisher", "first-page": "548", "journal-title": "J. Ethnopharmacol.", "key": "5683_CR55", "unstructured": "Jasprica, I. et al. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J. Ethnopharmacol. 110, 548–554 (2007).", "volume": "110", "year": "2007" }, { "DOI": "10.1080/00218839.2019.1695715", "author": "MJ Kwon", "doi-asserted-by": "publisher", "first-page": "413", "journal-title": "J. Apic. Res.", "key": "5683_CR56", "unstructured": "Kwon, M. J., Shin, H. M., Perumalsamy, H., Wang, X. & Ahn, Y. J. Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds. J. Apic. Res. 59, 413–425 (2020).", "volume": "59", "year": "2020" }, { "DOI": "10.1051/apido:19920306", "author": "M Amoros", "doi-asserted-by": "publisher", "first-page": "231", "journal-title": "Apidologie", "key": "5683_CR57", "unstructured": "Amoros, M., Sauvager, F., Girre, L. & Cormier, M. In vitro antiviral activity of propolis. Apidologie 23, 231–240 (1992).", "volume": "23", "year": "1992" }, { "DOI": "10.1007/s00228-020-02963-4", "author": "G Ragia", "doi-asserted-by": "publisher", "first-page": "1623", "journal-title": "Eur. J. Clin. Pharmacol.", "key": "5683_CR58", "unstructured": "Ragia, G. & Manolopoulos, V. G. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for Uncovering early COVID-19 drug therapies. Eur. J. Clin. Pharmacol. 76, 1623–1630 (2020).", "volume": "76", "year": "2020" }, { "DOI": "10.1155/2019/1907698", "doi-asserted-by": "crossref", "key": "5683_CR59", "unstructured": "Da, J. et al. Kaempferol promotes apoptosis while inhibiting cell proliferation via androgen-dependent pathway and suppressing vasculogenic mimicry and invasion in prostate cancer. Analytical Cellular Pathology (2019). (2019)." }, { "DOI": "10.14293/S2199-1006.1.SOR-.PP5BWN4.v1", "author": "G Halil Ibrahim Güler", "doi-asserted-by": "publisher", "journal-title": "So", "key": "5683_CR60", "unstructured": "Halil Ibrahim Güler, G., Tatar, O., Yildiz, A. O. & Belduz, S. K. An investigation of ethanolic propolis extracts: their potential inhibitor properties against ACE-II receptors for COVID-19 treatment by molecular Docking study Karadeniz technical university, faculty of science, department of molecular biology and gen. So https://doi.org/10.14293/S2199-1006.1.SOR-.PP5BWN4.v1 (2020).", "year": "2020" }, { "DOI": "10.1016/j.medidd.2023.100162", "author": "KS Yadav", "doi-asserted-by": "publisher", "first-page": "100162", "journal-title": "Med. Drug Discov", "key": "5683_CR61", "unstructured": "Yadav, K. S. et al. Microemulsions for enhancing drug delivery of hydrophilic drugs: exploring various routes of administration. Med. Drug Discov. 20, 100162 (2023).", "volume": "20", "year": "2023" }, { "DOI": "10.3390/antiox9010075", "author": "SM Osés", "doi-asserted-by": "publisher", "first-page": "75", "journal-title": "Antioxidants", "key": "5683_CR62", "unstructured": "Osés, S. M. et al. Phenolic profile, antioxidant capacities and enzymatic inhibitory activities of Propolis from different geographical areas: needs for analytical harmonization. Antioxidants 9, 75 (2020).", "volume": "9", "year": "2020" }, { "DOI": "10.1038/s41586-022-04474-x", "author": "B Meng", "doi-asserted-by": "publisher", "first-page": "706", "journal-title": "Nature", "key": "5683_CR63", "unstructured": "Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706–714 (2022).", "volume": "603", "year": "2022" }, { "DOI": "10.1371/journal.pone.0255622", "author": "C Pommerenke", "doi-asserted-by": "publisher", "first-page": "e0255622", "journal-title": "PLoS One", "key": "5683_CR64", "unstructured": "Pommerenke, C. et al. Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies. PLoS One. 16, e0255622 (2021).", "volume": "16", "year": "2021" }, { "author": "V Kumar", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "5683_CR65", "unstructured": "Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R. & Sundar, D. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J. Biomol. Struct. Dyn. 0, 1–13 (2020).", "volume": "0", "year": "2020" }, { "DOI": "10.2174/0115680266280720231221100004", "author": "V Kumar", "doi-asserted-by": "publisher", "first-page": "830", "journal-title": "Curr. Top. Med. Chem.", "key": "5683_CR66", "unstructured": "Kumar, V. et al. Anti-COVID-19 potential of Withaferin-A and caffeic acid phenethyl ester. Curr. Top. Med. Chem. 24, 830–842 (2024).", "volume": "24", "year": "2024" }, { "DOI": "10.3390/molecules26051232", "doi-asserted-by": "crossref", "key": "5683_CR67", "unstructured": "Ali, A. M. & Kunugi, H. Propolis, bee honey, and their components protect against coronavirus disease 2019 (Covid-19): A review of in silico, in vitro, and clinical studies. Molecules 26, 1–21 (2021)." }, { "DOI": "10.1371/journal.pone.0048072", "author": "T Hata", "doi-asserted-by": "publisher", "first-page": "e48072", "journal-title": "PLoS One", "key": "5683_CR68", "unstructured": "Hata, T. et al. Artepillin C, a major ingredient of Brazilian propolis, induces a pungent taste by activating TRPA1 channels. PLoS One. 7, e48072 (2012).", "volume": "7", "year": "2012" }, { "DOI": "10.1155/2013/267878", "doi-asserted-by": "crossref", "key": "5683_CR69", "unstructured": "Righi, A. A., Negri, G. & Salatino, A. Comparative Chemistry of Propolis from Eight Brazilian Localities. Evidence-Based Complementary and Alternative Medicine 1–14 (2013). (2013)." }, { "DOI": "10.1016/j.fitote.2020.104775", "doi-asserted-by": "publisher", "key": "5683_CR70", "unstructured": "Shahinozzaman, M. et al. A comprehensive review of its chemistry, bioavailability, and pharmacological properties. Fitoterapia vol. 147 Preprint at (2020). https://doi.org/10.1016/j.fitote.2020.104775" }, { "DOI": "10.1016/j.drudis.2020.03.008", "author": "H Maruta", "doi-asserted-by": "publisher", "first-page": "959", "journal-title": "Drug Discov Today", "key": "5683_CR71", "unstructured": "Maruta, H. & Kittaka, A. PAK1-blockers: potential therapeutics against COVID-19. Drug Discov Today. 25, 959–964 (2020).", "volume": "25", "year": "2020" }, { "DOI": "10.1128/JVI.02560-09", "author": "IY Chen", "doi-asserted-by": "publisher", "first-page": "7703", "journal-title": "J. Virol.", "key": "5683_CR72", "unstructured": "Chen, I. Y. et al. Upregulation of the chemokine (C-C Motif) ligand 2 via a severe acute respiratory syndrome coronavirus Spike-ACE2 signaling pathway. J. Virol. 84, 7703–7712 (2010).", "volume": "84", "year": "2010" }, { "DOI": "10.1177/095632020801900102", "author": "T Shimizu", "doi-asserted-by": "publisher", "first-page": "7", "journal-title": "Antivir Chem. Chemother.", "key": "5683_CR73", "unstructured": "Shimizu, T. et al. Anti-Influenza virus activity of Propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem. Chemother. 19, 7–13 (2008).", "volume": "19", "year": "2008" }, { "DOI": "10.1016/j.jep.2021.114255", "doi-asserted-by": "crossref", "key": "5683_CR74", "unstructured": "Ferreira, J. C. et al. Baccharin and p-coumaric acid from green propolis mitigate inflammation by modulating the production of cytokines and eicosanoids. J Ethnopharmacol 278, 1–8 (2021)." }, { "DOI": "10.1007/s10787-025-01647-8", "author": "RA El-Shiekh", "doi-asserted-by": "publisher", "first-page": "1209", "journal-title": "Inflammopharmacology", "key": "5683_CR75", "unstructured": "El-Shiekh, R. A., Radi, M. H. & Abdel-Sattar, E. Unveiling the therapeutic potential of aromadendrin (AMD): a promising anti-inflammatory agent in the prevention of chronic diseases. Inflammopharmacology 33, 1209–1220 (2025).", "volume": "33", "year": "2025" }, { "DOI": "10.1155/2021/7169211", "doi-asserted-by": "crossref", "key": "5683_CR76", "unstructured": "Chen, Y. et al. Identifying Active Compounds and Mechanism of Camellia nitidissima Chi on Anti-Colon Cancer by Network Pharmacology and Experimental Validation. Evidence-based Complementary and Alternative Medicine (2021). (2021)." }, { "DOI": "10.33263/BRIAC134.324", "doi-asserted-by": "crossref", "key": "5683_CR77", "unstructured": "Aijaz, M. et al. Chemical, biological, and Pharmacological prospects of caffeic acid. Biointerface Res. Appl. Chem 13, 1–26 (2023)." }, { "DOI": "10.35652/IGJPS.2021.112007", "author": "S Sharma", "doi-asserted-by": "publisher", "first-page": "120", "journal-title": "Indo Global J. Pharm. Sci.", "key": "5683_CR78", "unstructured": "Sharma, S., Khatkar, A. & Kakkar, S. A. Review: p-Coumaric acid, A medicinally important phenolic acid moiety. Indo Global J. Pharm. Sci. 11, 120–129 (2021).", "volume": "11", "year": "2021" }, { "DOI": "10.3390/plants11233399", "doi-asserted-by": "crossref", "key": "5683_CR79", "unstructured": "Schepetkin, I. A. et al. Neutrophil Immunomodulatory Activity of Nerolidol, a Major Component of Essential Oils from Populus balsamifera Buds and Propolis. Plants 11, (2022)." }, { "DOI": "10.1590/2175-7860202172041", "doi-asserted-by": "crossref", "key": "5683_CR80", "unstructured": "de Costa, I. F. et al. J. B. Anti-mycobacterial and immunomodulatory activity of n-hexane fraction and spathulenol from Ocotea notata leaves. Rodriguésia 72, (2021)." }, { "author": "MA Hassan", "first-page": "987", "journal-title": "J. Med. Pharm. Chem. Res.", "key": "5683_CR81", "unstructured": "Hassan, M. A. et al. A comparative study of selected immunological markers on children with normal tonsils, simple hypertrophic tonsils, and recurrently inflamed tonsils. J. Med. Pharm. Chem. Res. 5, 987–999 (2023).", "volume": "5", "year": "2023" }, { "DOI": "10.3390/cells10081900", "author": "DWL Wong", "doi-asserted-by": "publisher", "first-page": "1900", "journal-title": "Cells", "key": "5683_CR82", "unstructured": "Wong, D. W. L. et al. Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells 10, 1900 (2021).", "volume": "10", "year": "2021" }, { "DOI": "10.1128/spectrum.01347-23", "author": "TM Lima", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Microbiol. Spectr.", "key": "5683_CR83", "unstructured": "Lima, T. M. et al. Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiol. Spectr. 11, 1–14 (2023).", "volume": "11", "year": "2023" }, { "DOI": "10.3390/ijms22157914", "author": "SY Cheon", "doi-asserted-by": "publisher", "first-page": "7914", "journal-title": "Int. J. Mol. Sci.", "key": "5683_CR84", "unstructured": "Cheon, S. Y. & Koo, B. N. Inflammatory response in COVID-19 patients resulting from the interaction of the inflammasome and SARS-CoV-2. Int. J. Mol. Sci. 22, 7914 (2021).", "volume": "22", "year": "2021" }, { "DOI": "10.7554/eLife.68563", "doi-asserted-by": "crossref", "key": "5683_CR85", "unstructured": "Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. Elife 10, (2021)." }, { "DOI": "10.3390/tropicalmed9010013", "author": "AA Al-Qahtani", "doi-asserted-by": "publisher", "first-page": "13", "journal-title": "Trop. Med. Infect. Dis.", "key": "5683_CR86", "unstructured": "Al-Qahtani, A. A., Alhamlan, F. S. & Al-Qahtani, A. A. Pro-Inflammatory and Anti-Inflammatory interleukins in infectious diseases: A comprehensive review. Trop. Med. Infect. Dis. 9, 13 (2024).", "volume": "9", "year": "2024" }, { "DOI": "10.1007/s00217-024-04522-y", "author": "Z Can", "doi-asserted-by": "publisher", "first-page": "2059", "journal-title": "Eur. Food Res. Technol.", "key": "5683_CR87", "unstructured": "Can, Z., Birinci, C., Kara, Y., Esertaş, Ü. Z. Ü. & Kolaylı, S. Determination of phenolic content and bioactive characterization of Anatolian propolis. Eur. Food Res. Technol. 250, 2059–2068 (2024).", "volume": "250", "year": "2024" }, { "DOI": "10.3201/eid2606.200516", "author": "J Harcourt", "doi-asserted-by": "publisher", "first-page": "1266", "journal-title": "Emerg. Infect. Dis.", "key": "5683_CR88", "unstructured": "Harcourt, J. et al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, united States. Emerg. Infect. Dis. 26, 1266–1273 (2020).", "volume": "26", "year": "2020" }, { "DOI": "10.3201/eid2608.201246", "author": "X Lu", "doi-asserted-by": "publisher", "first-page": "1654", "journal-title": "Emerg. Infect. Dis.", "key": "5683_CR89", "unstructured": "Lu, X. et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1654–1665 (2020).", "volume": "26", "year": "2020" }, { "author": "LJ Reed", "first-page": "493", "journal-title": "Am. J. Hygiene", "key": "5683_CR90", "unstructured": "Reed, L. J. & Muench, H. Journal of hygiene. Am. J. Hygiene. 27, 493–497 (1938).", "volume": "27", "year": "1938" } ], "reference-count": 90, "references-count": 90, "relation": {}, "resource": { "primary": { "URL": "https://www.nature.com/articles/s41598-025-05683-w" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy", "volume": "15" }